Tenants in the news: Shire
November 2nd, 2015
LTC tenant Shire recently announced it had agreed to acquire Burlington-based Dyax Corporation for $6.5 billion.
LTC tenant Shire recently announced it had agreed to acquire Burlington-based Dyax Corporation for $6.5 billion. Dyax develops treatments for the rare genetic condition known as hereditary angioedema.
“The highly complementary transaction aligns with and accelerates our strategy to build a global biotechnology company focused on rare diseases and specialty conditions,” Shire CEO Flemming Ornskov said.
Read the company’s full press release for more on the deal.